Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1923]
News [3529]
Articles [90]
Editorials [5]
Conferences [156]
elearning [19]
Better understandings of gene mutations aid diagnostic tools in CLL
Dr Elías Campo - University of Barcelona, Barcelona, Spain
Better understandings of gene mutations aid diagnostic tools in CLL ( Dr Elías Campo - University of Barcelona, Barcelona, Spain )
19 Jun 2014
Novel Bcl-2 specific inhibitor updated results confirm substantial activity and...
Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia
Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL ( Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia )
19 Jun 2014
Comment: Advances in haematological cancer presented at EHA 2014
Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands
Comment: Advances in haematological cancer presented at EHA 2014 ( Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands )
19 Jun 2014
Advances in chronic lymphocytic leukaemia: Expert panel discussion
Prof Peter Hillmen; Prof John Gribben; Prof Stephen Mulligan
Advances in chronic lymphocytic leukaemia: Expert panel discussion ( Prof Peter Hillmen; Prof John Gribben; Prof Stephen Mulligan )
19 Jun 2014
Genetically modified T cells fight haematological cancer
Dr Roman Galetto - Cellectis Therapeutics, Paris, France
Genetically modified T cells fight haematological cancer ( Dr Roman Galetto - Cellectis Therapeutics, Paris, France )
19 Jun 2014
Investigating anticarcinogenic compounds as an alternative to chemo
Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy
Investigating anticarcinogenic compounds as an alternative to chemo ( Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy )
6 Jun 2014
HPV-targeted adoptive T Cell therapy for advanced cervical cancer
Dr Christian Hinrichs - Center for Cancer Research, Bethesda, USA
HPV-targeted adoptive T Cell therapy for advanced cervical cancer ( Dr Christian Hinrichs - Center for Cancer Research, Bethesda, USA )
2 Jun 2014
PD-1 targeting immunotherapy MK-3475 has high, long-lasting activity against...
Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, US
PD-1 targeting immunotherapy MK-3475 has high, long-lasting activity against metastatic melanoma ( Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, US )
2 Jun 2014
Ipilimumab and nivolumab achieves long-term survival in advanced melanoma
Prof Mario Sznol - Yale Cancer Center, New Haven, USA
Ipilimumab and nivolumab achieves long-term survival in advanced melanoma ( Prof Mario Sznol - Yale Cancer Center, New Haven, USA )
2 Jun 2014
Adjuvant ipilimumab improves recurrence-free survival in high-risk stage III...
Prof Alexander M. Eggermont, Erasmus University, Rotterdam, The Netherlands
Adjuvant ipilimumab improves recurrence-free survival in high-risk stage III melanoma ( Prof Alexander M. Eggermont, Erasmus University, Rotterdam, The Netherlands )
2 Jun 2014
HPV-targeted adoptive T Cell therapy may provide a new personalised strategy...
Dr Christian S. Hinrichs - Center for Cancer Research, Bethesda, US
HPV-targeted adoptive T Cell therapy may provide a new personalised strategy for advanced cervical cancer ( Dr Christian S. Hinrichs - Center for Cancer Research, Bethesda, US )
2 Jun 2014
Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for...
Dr Steven O'Day - Beverly Hills Cancer Center, Los Angeles, USA
Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer ( Dr Steven O'Day - Beverly Hills Cancer Center, Los Angeles, USA )
2 Jun 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation